Dr. Gustavo Aguirre-Chang Profile picture
Sep 2, 2022 3 tweets 2 min read Read on X
NATTOKINASE DEGRADES THE SPIKE PROTEIN OF SARS COV2
in this way inhibits the entry of the virus into host cells
So in addition to using it as a Fibrinolytic, Anticoagulant,Antiplatelet
is added this effect against Viral Load of #Nattokinase
doi.org/10.3390/molecu…
#LongCovid #CFS Image
There are several other studies of the use of NATTOKINASE
In the link is a study that included 153patients with deep vein thrombosis,phlebitis or venous insufficiency
Conclude that NK represents an efficient/safe treatment in patien. with vascular diseases
doi.org/10.3390/nu1306…
In this study
they point out that Nattokinase was superior in safety to t-PA, which is a traditional thrombolytic for IV use
A lower risk of bleeding was observed with the use of NK
And they conclude that NK is an excellent antithrombotic and with low risk
doi.org/10.1007/s10068…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Dr. Gustavo Aguirre-Chang

Dr. Gustavo Aguirre-Chang Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @Aguirre1Gustavo

Aug 25
ANTIVIRAL THERAPIES
FOR PERSISTENT COVID/LONG COVID
83% SUCCESS
70 of 84 cases with the aggravating factor of immunosuppression

The types of treatment were grouped into:
Prolonged Antiviral therapy
Combination Antivirals
Mixed therapy: Antiviral +Antibody
onlinelibrary.wiley.com/doi/10.1111/ti…
Image
Read 5 tweets
Aug 13
Viral persistence has already been sufficiently demonstrated
It was simple for us to do it since April2020
They should no longer spend on studies that do not provide solutions
There are several Antivirals
These studies are postponed
&DrugResistance advance
Read 7 tweets
Jul 6
A LOW LEVEL OF OXYGEN IN THE MUSCLES
(HYPOXIA)
IS THE MOST FREQUENT CAUSE OF
CHRONIC FATIGUE
POST-EXERTIONAL MALAISE:PEM
NON-RESTORATIVE SLEEP
MUSCULOSKELETAL STIFFNESS AND PAIN WHEN WAKING UP

This occurs in
ME/CFS
Fibromyalgia
LongCOVID
Post-Vac Syn
Other researchgate.net/publication/38…
Image
Read 6 tweets
Jun 2
Histamine causes greater endothelial damage in COVID
by increasing the number of complement C3/C3b binding sites
on the surface of endothelial cells
This
is one more support for our Antihistamine Protocols
before starting Antivirals

doi.org/10.31857/S0233…

Image
Read 5 tweets
Feb 13
This study included Biopsies of endothelial tissue and thrombotic clots
Fig.4 shows SARS CoV2 (light circles)
inside clots adhered to infected endothelial cells

It confirms what we graphed almost 3years ago
and we call them BIOCLOTS
mdpi.com/2075-1729/14/2…

Image
It will still take years
for it to be accepted that Microclots
serve as a protective barrier
for viruses and other microorganisms to persist
This occurs in several chronic diseases
They are diseases based on Biofilms & Reservoirs
with persistent infections
Most of the symptoms of LongCOVID
they are associated with Hypoperfusion, Hipercoagulability & Microclots (HHM)
because it is a Persistent Infectious Disease that affects the blood vessels

The second most common cause of LongCOVID symptoms is Histaminosis
Read 4 tweets
Feb 12
STUDY BASED ON BIOPSIES SHOWS IN SITU PRESENCE OF SARS COV-2
IN ENDOTHELIAL CELLS AND CLOTS

Findings support our Protocols established since 2020
The main thing is to reduce the VIRAL LOAD
Anticoagulant & Antiplatelet Therapy does not go against the CAUSE
mdpi.com/2075-1729/14/2…
Image
If there are Persistent Microclots
so
there is a Persistent Infection
which is the main CAUSE to treat
The patient may spend years taking Anticoagulants/Antiplatelets
while
with a Protocol with 3-6 Antivirals the patient can recover in days or a few months
In May 2020 we published the COVID Protocol
applicable for cases with Persistent Symptoms
and with Rebound/Reactivation of the infection

The First thing is to reduce the VIRAL LOAD
Second is to reduce Platelet Hyperactivity and Break Down Persistent Clots
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(